The goal of the West Virginia Clinical and Translation Science Institute's (WVCTSI) IDeA-CTR application is to expand our infrastructure for, and practice of, clinical and translational research to a level competitive for a Clinical and Translational Science Award (CTSA). To this end, the WVCTSI was established in 2008 as the organizational home supporting research to address the health and healthcare needs of the people of West Virginia and Central Appalachia, and ultimately to eliminate health disparities. To realize our ambitious goal, the WVCTSI, which includes West Virginia University, Charleston Area Medical Center, West Virginia School of Osteopathic Medicine, and West Virginia United Health Systems, has partnered with the Appalachian Translational Research Institute, which was founded by our IDeA state partner and CTSA recipient the University of Kentucky. The WVCTSI will achieve its goal through pursuit of three aims: 1) Grow the WVCTSI as an academic home and a catalyst for clinical and translational research that targets cancer, cardiovascular-stroke, and obesity related diseases;2) Establish cross cutting research partnerships among the WVCTSI partnered institutions and collaborating CTSAs at University of Kentucky, Ohio State University, and Indiana University to increase our research capacity;and 3) Utilize innovative recruitment, training, and mentoring strategies to develop clinical and translational scientists at each of the WVCTSI institutions.
These aims are addressed through recruitment and support of clinical and translational scientists and a broad educational and mentoring program. In addition, participating faculty are provided with research resources that include biostatistics, clinical informatics, and access to a range of pilot funding mechanisms. Furthermore, mechanisms to streamline regulatory processes without compromising human subject protections and to engage communities fully in the research agenda are being developed. Finally, to ensure accountability and quality improvement, a robust evaluation program has been established. Overall, the WVCTSI has developed a strong infrastructure to increase the number of extramural funded clinical and translational researchers and has a well-considered plan for enhancing capacity and productivity over the next five years, positioning us for competitiveness for a CTSA.

Public Health Relevance

West Virginia suffers from numerous health disparities, notably for cancer, cardiovascular-stroke, and obesity related diseases. The WVCTSI, which includes health sciences and clinical institutions in the state and throughout central Appalachia, provides a means for the IDeA-CTR to enhance clinical and translational research and supporting infrastructure. This will result in long-term improvements to health healthcare through translation of research findings to clinical care and public health policy.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54GM104942-01
Application #
8339639
Study Section
Special Emphasis Panel (ZRR1-RI-3 (01))
Program Officer
Gorospe, Rafael
Project Start
2012-08-15
Project End
2017-06-30
Budget Start
2012-08-15
Budget End
2017-06-30
Support Year
1
Fiscal Year
2012
Total Cost
$19,581,898
Indirect Cost
$5,716,014
Name
West Virginia University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
191510239
City
Morgantown
State
WV
Country
United States
Zip Code
26506
Sobinov, Anton; Yakovenko, Sergiy (2018) Model of a bilateral Brown-type central pattern generator for symmetric and asymmetric locomotion. J Neurophysiol 119:1071-1083
Sheppard, Jordan G; Frazier, Keely R; Saralkar, Pushkar et al. (2018) Disulfiram-based disulfides as narrow-spectrum antibacterial agents. Bioorg Med Chem Lett 28:1298-1302
Kishan, Amar U; Cook, Ryan R; Ciezki, Jay P et al. (2018) Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. JAMA 319:896-905
Wiener, R Constance; Waters, Christopher; Doris, Joan et al. (2018) Comparison of Dental Students' Self-Evaluation and Faculty Evaluation of Communication Skills During a Standardized Patient Exercise. J Dent Educ 82:1043-1050
Cox, Stephanie; Brode, Cassie (2018) Predictors of Binge Eating among Bariatric Surgery Candidates: Disinhibition as a Mediator of the Relationship Between Depressive Symptoms and Binge Eating. Obes Surg 28:1990-1996
Robillard, Pierre-Yves; Boukerrou, Malik; Bonsante, Francesco et al. (2018) Linear association between maternal age and spontaneous breech presentation in singleton pregnancies after 32 weeks gestation. J Matern Fetal Neonatal Med 31:376-381
van Kleef, Monique E A M; Bates, Mark C; Spiering, Wilko (2018) Endovascular Baroreflex Amplification for Resistant Hypertension. Curr Hypertens Rep 20:46
Wu, Xiaoliang; Zhu, Lin; Ma, Patrick C (2018) Next-Generation Novel Noninvasive Cancer Molecular Diagnostics Platforms Beyond Tissues. Am Soc Clin Oncol Educ Book :964-977
Povroznik, Jessica M; Engler-Chiurazzi, Elizabeth B; Nanavati, Tania et al. (2018) Absolute lymphocyte and neutrophil counts in neonatal ischemic brain injury. SAGE Open Med 6:2050312117752613
Zhang, Yu; Chen, Shiguo; Wei, Chaoyang et al. (2018) Flavonoids from Chinese bayberry leaves induced apoptosis and G1 cell cycle arrest via Erk pathway in ovarian cancer cells. Eur J Med Chem 147:218-226

Showing the most recent 10 out of 998 publications